Organization · Venture Capital
Evoce Capital
Evoce Capital is a U.S.-based venture capital firm that invests in seed to Series A companies across various industries, focusing on founder-led teams with strong technical leadership. They provide funding ranging from $150K to $2M.
Overview
What Evoce Capital does
What Evoce Capital is
Evoce Capital is a U.S.-based venture capital firm that invests in seed to Series A companies across various industries, focusing on founder-led teams with strong technical leadership. They provide funding ranging from $150K to $2M.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find Evoce Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Evoce Capital as a funder
Investment thesis
Evoce Capital focuses on backing ambitious founder-led teams with strong technical leadership, particularly in complex industries and regulatory environments. The firm aims to bridge the gap into pre-institutional funding, supporting companies with early revenue and a path toward institutional Series A financing.
Focus narrative
Evoce Capital invests across a wide range of industries, with a particular emphasis on healthcare and fintech. The organization prioritizes backing teams that demonstrate strong technical leadership and ambition. Evoce Capital offers initial funding ranging from $150,000 to $2 million, targeting U.S.-based companies with revenues between $100,000 and $20 million.
Value beyond capital
Evoce Capital adds value to its portfolio companies by providing not only capital but also access to a network of experienced entrepreneurs and advisors. The firm leverages its team's extensive operational experience in regulated industries to help founders navigate challenges and accelerate growth.
Terms and economics
- Typical check
- $150,000–$2,000,000
Focus and fit
- Stages
- Seed · Series A
- Sectors
- HealthcareFintech
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 3
Portfolio context
Evoce Capital's notable portfolio includes: Surf Therapeutics: A clinical-stage ultrasound neuromodulation company that recently secured a seed extension bringing total funding to $6 million. Beanstack: An education and reading engagement software platform, where Evoce participated in a $1.5 million financing round. Intero Biosystems: An organoid and preclinical drug-discovery platform that received $2 million in funding with Evoce's involvement.
Common questions
What to know about Evoce Capital
Upseed classifies Evoce Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.